Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

NICE backs expanded use of Brilique in final guidance

AZ’s maintenance therapy recommended for long-term use, post-heart attack

Bristol Myers Squibb logo

BMS wins early UK access for Opdivo in Hodgkin’s lymphoma

Cancer treatment approved by the MHRA for use before EU licence in place

- PMLiVE

The Book of Boredom

Integrated communications might sound boring but it's a cause well worth believing in

- PMLiVE

PureTech Health appoints chief scientific officer

Dr Joseph Bolen brings 30 years of clinical experience to the biotech

- PMLiVE

Metrion Biosciences expands operations team

Dr Andrew Southan appointed head of commercial operations

Focusing on customers, not on the channels

Multichannel Excellence Conference 2016: Customer-centricity in focus

Anthill Agency

Celgene building

Celgene engages IBM Watson for patient safety work

Aims to improve its pharmacovigilance methods with a new cloud-based platform

- PMLiVE

NICE backs Eisai’s Halaven for breast cancer

Reverses 2012 rejection due to new data and patient access discount

- PMLiVE

Torrid times at Gilead lead to calls for a major M&A deal

HIV portfolio sales down almost 10% to $7.5bn despite strong $533m start for Epclusa

Immunisation politicised

The case of Human Papilloma Virus

- PMLiVE

Enterprise Therapeutics appoints CEO

Dr John Ford will lead the UK drug discovery company

- PMLiVE

NICE set to reject Merck’s Erbitux for head and neck cancer

Draft guidance rules the treatment does not provide value for money

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links